Anhedonia refers to the reduced capacity to feel pleasure or the complete inability to experience enjoyment from once rewarding activities. The word comes from Greek: “an,” meaning without, and “hedone,” meaning pleasure. First studied by ancient Greek philosophers and later classified as a symptom of psychopathology in the early 19th century, anhedonia is now recognized as one of the most clinically significant markers of several mental health conditions, particularly major depressive disorder (Ho & Sommers, 2013).
Understanding what anhedonia means goes beyond a simple definition. It touches on the brain’s reward circuitry, a person’s emotional world, and the quality of their relationships. People experiencing anhedonia often describe a kind of gray flatness where previously meaningful activities feel hollow, social connection loses its pull, and even basic physical pleasures stop registering. The experience can be confusing and isolating, in part because it is invisible to others and difficult to put into words.
The Neuroscience Behind Anhedonia
To understand anhedonia, it helps to understand how the brain processes reward. When a person anticipates something enjoyable and then experiences it, a network of brain structures fires in sequence. Dopamine, a neurotransmitter central to motivation and reinforcement, plays a pivotal role in this process. Disruptions within dopaminergic pathways have long been studied as a key contributor to anhedonia (Gorwood, 2008).
The Role of the Dopamine Reward System
The nucleus accumbens, a structure embedded in the basal ganglia, is often referred to as the brain’s “pleasure center.” Research has repeatedly linked dysfunction in this region to the experience of anhedonia. However, more recent work has considerably refined this picture. The nucleus accumbens does not simply generate pleasure; it is part of a broader mesolimbic circuit that includes the ventral tegmental area, the prefrontal cortex, and the amygdala. When any part of this circuit is disrupted, the result is not just reduced enjoyment but impaired motivation to seek out rewarding experiences at all (Gorwood, 2008; Cooper et al., 2018).
The “Wanting” Versus “Liking” Distinction
Contemporary neuroscience draws a useful distinction between two separable components of reward: wanting and liking. “Wanting” refers to the motivational drive to pursue a reward, while “liking” refers to the hedonic pleasure experienced upon receiving it. Anhedonia can affect either or both of these systems. A person might still want food but not enjoy eating it, or might lose both the motivation to see friends and the pleasure of being with them. This distinction matters clinically because it shapes which treatments are most likely to be effective (Cooper et al., 2018; Treadway & Zald, 2011).
Types of Anhedonia
Researchers and clinicians generally divide anhedonia into two broad categories, though these are not mutually exclusive. Understanding which type a person is experiencing can help guide both assessment and treatment.
Social Anhedonia
Social anhedonia involves a diminished interest in and enjoyment of social interactions. Rather than being introverted, a person with social anhedonia does not find connection with others rewarding. They may withdraw from friendships, reduce contact with family members, and feel little motivation to participate in group activities, even activities they previously looked forward to. The key distinction from introversion is that the withdrawal is not a preference; it reflects a genuine absence of positive emotional return (Ho & Sommers, 2013).
Social anhedonia is associated with both depressive disorders and schizophrenia spectrum conditions. Individuals experiencing it may also develop heightened anxiety in social contexts, since the ordinary comfort that social interaction provides is absent, leaving them without the natural buffers that normally reduce interpersonal stress. When social anhedonia co-occurs with social anxiety, it can significantly reduce a person’s quality of life and increase the risk of long-term social isolation.
Physical Anhedonia
Physical anhedonia refers to a reduced capacity to experience pleasure from sensory input. This can include eating, physical touch, exercise, sexual activity, music, and other bodily experiences. People with physical anhedonia may describe food as tasting flat, physical affection as feeling neutral, or activities like swimming or hiking as producing no emotional uplift.
In men, physical anhedonia can manifest as ejaculatory anhedonia, a condition in which ejaculation occurs without the associated sensation of pleasure. Though less commonly discussed, women can experience a parallel absence of pleasurable sensation during orgasm. Sexual anhedonia of this kind is frequently linked to underlying depression or to the side effects of certain antidepressant medications. The experience of physical anhedonia often extends beyond sexual functioning and can affect virtually any sensory domain.
Conditions Associated With Anhedonia
Anhedonia is not a standalone diagnosis. Rather, it is a symptom that can appear across a wide range of mental health and medical conditions. Identifying the underlying condition is essential for determining an effective treatment approach.
Anhedonia and Depression
Anhedonia is one of the two core symptoms of major depressive disorder, according to diagnostic criteria, alongside persistent depressed mood. It is present in the majority of people diagnosed with MDD and is considered one of the most treatment-resistant features of the illness. Research has found that depression with prominent anhedonia may respond less robustly to standard selective serotonin reuptake inhibitors (SSRIs), in part because serotonin can suppress dopamine release in several brain areas, potentially blunting the reward system further (Treadway & Zald, 2011).
For those living with or dating someone with depression, the presence of anhedonia can strain relationships significantly, since a partner experiencing it may appear emotionally withdrawn or indifferent even when they are not. Understanding the condition is important for both the person experiencing it and those close to them.
Anhedonia and Schizophrenia
Anhedonia is a prominent negative symptom of schizophrenia and schizotypy, a range of personality traits associated with psychosis risk. Research has identified an important difference in how anhedonia presents in schizophrenia compared to depression. Individuals with schizophrenia tend to show relatively preserved consummatory pleasure, meaning they can enjoy an experience in the moment, but demonstrate greater deficits in anticipatory pleasure, which affects their motivation to pursue rewarding activities in the first place (Pelc et al., 2025).
This distinction has treatment implications. It suggests that interventions targeting motivational deficits may be more relevant for schizophrenia-related anhedonia than those focused primarily on enhancing hedonic capacity. Social anhedonia, in particular, can predict future schizophrenia spectrum diagnoses in individuals not yet showing full psychotic symptoms, making it an important area for early clinical identification and support.
Anhedonia and Substance Use Disorders
Anhedonia commonly accompanies substance use disorders and is frequently observed both during active use and in withdrawal. Alcohol, opioids, stimulants, and nicotine all affect dopaminergic pathways in ways that can blunt the reward system over time. Chronic substance use can essentially recalibrate the brain’s baseline, making natural rewards feel insufficient by comparison.
During recovery, anhedonia can persist for weeks or months as the brain’s reward circuitry slowly recalibrates. This protracted anhedonia is a meaningful predictor of relapse, since the inability to feel pleasure from ordinary activities removes an important motivation to maintain sobriety. Mindfulness-based interventions have shown particular promise in reducing anhedonia during opioid recovery by helping individuals reconnect with the savoring of natural rewards (Garland et al., 2023).
Other Conditions Linked to Anhedonia
Beyond depression, schizophrenia, and substance use, anhedonia can arise in the context of bipolar disorder (particularly during depressive phases), post-traumatic stress disorder, Parkinson’s disease, diabetes, and cardiovascular disease. It is also observed in eating disorders, where the absence of pleasure from food may compound the condition’s severity. In some cases, anhedonia appears without a clear psychiatric diagnosis, which can make it especially challenging to address clinically. When personality disorders and trauma are present, anhedonia may be one of several overlapping symptoms that complicate the clinical picture.
Recognizing the Signs: Symptoms of Anhedonia
Anhedonia does not always announce itself clearly. People experiencing it often report a vague sense that something is off, that life feels muted, or that activities they used to enjoy now feel like obligations. Common signs include a persistent loss of interest in hobbies, reduced verbal and nonverbal expressiveness, a tendency toward social withdrawal, low self-esteem, and a pattern of going through the motions without any accompanying sense of engagement or satisfaction.
Some individuals describe artificial or performed emotions, smiling or laughing in social situations without genuinely feeling positive. Others notice a reduced sex drive or find that physical touch no longer feels comforting. Depressed mood may or may not accompany anhedonia; the two can co-occur, but anhedonia can also appear in people who do not report feeling sad. This is one reason the condition is sometimes missed in clinical settings, where assessments may focus more heavily on mood than on the loss of positive experience. A thorough evaluation by a trained clinician will typically ask directly about changes in pleasure and motivation, not only about sadness or low mood.
Does Anhedonia Increase Suicide Risk?
The relationship between anhedonia and suicidal behavior has received considerable research attention. Studies have found that anhedonia in the context of depression is associated with increased suicide risk, independent of other depressive symptoms. Because anhedonia reduces the capacity to experience positive emotion, it can remove psychological buffers against suicidal ideation, such as the anticipation of future pleasurable events or the comfort derived from social connection (Bonanni et al., 2019).
This does not mean that every person experiencing anhedonia is at risk for suicide, but it does underscore the importance of taking the symptom seriously and seeking professional support promptly. Anyone experiencing a persistent inability to feel pleasure, particularly alongside depressive mood or any thoughts of self-harm, should contact a mental health professional as a matter of priority.
Treatment Options for Anhedonia
There are currently no medications specifically approved for anhedonia as a standalone condition, and existing interventions vary considerably in their effectiveness. The most productive approach generally begins with identifying and treating the underlying condition driving the symptom, while also addressing anhedonia directly through targeted strategies.
Psychotherapy Approaches
Psychotherapy is the most consistently supported intervention for anhedonia across various underlying conditions. Behavioral Activation, a structured component of cognitive behavioral therapy, targets anhedonia directly by gradually reintroducing rewarding activities into a person’s routine, beginning with low-effort activities and building toward more complex ones. The goal is not to force enjoyment but to restore the behavioral patterns that allow pleasure to return over time.
A 2024 randomized controlled trial compared Behavioral Activation Therapy for Anhedonia with Mindfulness-Based Cognitive Therapy and found that both produced meaningful reductions in anhedonia, with neither demonstrating clear superiority over the other (Cernasov et al., 2024). Mindfulness-Based Cognitive Therapy helps people notice and gently engage with present-moment experiences, which may help counter the emotional blunting associated with anhedonia. The finding that multiple therapeutic approaches can address anhedonia meaningfully is encouraging, since it allows for individualized treatment planning based on a person’s history and preferences.
Medication and Emerging Pharmacological Treatments
Antidepressant medications, particularly SSRIs, are often prescribed as a first-line treatment for conditions that include anhedonia. However, as noted above, SSRIs carry the potential to worsen anhedonia in some individuals by reducing dopamine availability. In these cases, clinicians may consider bupropion, a dopamine and norepinephrine reuptake inhibitor, or augmentation strategies that target the dopaminergic system more directly.
Ketamine has emerged as one of the more promising treatments for treatment-resistant anhedonia. Research has found that ketamine can produce rapid improvements in anhedonia in individuals with treatment-resistant depression, with effects that appear distinct from its broader antidepressant properties (Kwaśny et al., 2024). This suggests anhedonia may respond to ketamine through mechanisms beyond simple mood elevation. Kappa-opioid receptor antagonists represent another emerging pharmacological avenue, with early clinical trials showing evidence of antianhedonic effects. These treatments remain investigational but represent a meaningful advance in targeting anhedonia specifically rather than as a secondary benefit of broader depression treatment.
Lifestyle Interventions
Exercise is increasingly recognized as a meaningful adjunct to both therapy and medication for anhedonia. Aerobic exercise stimulates dopamine release and activates the same reward pathways that are dysregulated in anhedonia. Research has explored exercise as a way to prime the effectiveness of CBT in depression, with the hypothesis that physical activity may lower the activation threshold for experiencing positive affect, making subsequent therapeutic work more effective.
Mindfulness practice, particularly when integrated into structured clinical treatments, has shown the capacity to help individuals reconnect with the pleasurable dimensions of everyday experiences. Mindfulness-Oriented Recovery Enhancement, developed for individuals in opioid recovery, has produced measurable improvements in anhedonia by enhancing neurophysiological responses to natural rewards (Garland et al., 2023). Sleep hygiene, social engagement, and structured daily routines also support the gradual restoration of the reward system’s sensitivity over time.
When to Seek Help
If you have noticed a persistent loss of interest in activities you once found meaningful, or if emotional experiences feel consistently flat or absent, these are signs worth bringing to a professional. Anhedonia is not a character flaw or a sign of weakness, and it does not respond reliably to willpower alone. A mental health professional can help identify what is driving the symptom, rule out medical contributors, and develop a treatment plan suited to your situation.
Effective care for anhedonia may involve a combination of therapy, medication, and lifestyle change, and the right combination varies from one person to the next. Reaching out is often the most difficult step, but it is also the one that makes every other step possible. If you are uncertain where to begin, a primary care physician can provide an initial assessment and refer you to a specialist.
Sources
- Cernasov, P. M., Walsh, E. C., Nagy, G. A., Kinard, J. L., Kelley, L., Phillips, R. D., Pisoni, A., Diehl, J., Haworth, K., West, J., Freeman, L., Pfister, C., Scott, M., Daughters, S. B., Gaylord, S., Dichter, G. S., & Smoski, M. J. (2024). A parallel-arm, randomized trial of Behavioral Activation Therapy for anhedonia versus mindfulness-based cognitive therapy for adults with anhedonia. Behaviour research and therapy, 182, 104620. https://doi.org/10.1016/j.brat.2024.104620
- Bonanni, L., Gualtieri, F., Lester, D., Falcone, G., Nardella, A., Fiorillo, A., & Pompili, M. (2019). Can anhedonia be considered a suicide risk factor? A review of the literature. Medicina, 55(8), Article 458. https://doi.org/10.3390/medicina55080458
- Cooper, J. A., Arulpragasam, A. R., & Treadway, M. T. (2018). Anhedonia in depression: biological mechanisms and computational models. Current opinion in behavioral sciences, 22, 128–135. https://doi.org/10.1016/j.cobeha.2018.01.024
- Garland, E. L., Fix, S. T., Hudak, J. P., Bernat, E. M., Nakamura, Y., Hanley, A. W., Donaldson, G. W., Marchand, W. R., & Froeliger, B. (2023). Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards. Psychological medicine, 53(5), 2085–2094. https://doi.org/10.1017/S0033291721003834
- Gorwood, P. (2008). Neurobiological mechanisms of anhedonia. Dialogues in Clinical Neuroscience, 10(3), 291–299. https://doi.org/10.31887/DCNS.2008.10.3/pgorwood
- Ho, N., & Sommers, M. (2013). Anhedonia: A concept analysis. Archives of Psychiatric Nursing, 27(3), 121–129. https://doi.org/10.1016/j.apnu.2013.02.001
- Kwaśny, A., Cubała, W. J., & Włodarczyk, A. (2024). Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression. Frontiers in psychiatry, 15, 1334293. https://doi.org/10.3389/fpsyt.2024.1334293
- Pelc, M. L., Białek, A. B., Stasiewicz, O. A., Sobecka, N. O., & Soroka, E. (2025). Anhedonia in Depressive Disorder and Schizophrenia: An Overview of Causes, Diagnosis, and Treatment. Medical science monitor : international medical journal of experimental and clinical research, 31, e950368. https://doi.org/10.12659/MSM.950368
- Treadway, M. T., & Zald, D. H. (2011). Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience & Biobehavioral Reviews, 35(3), 537–555. https://doi.org/10.1016/j.neubiorev.2010.06.006
Tracy is a Licensed Professional Counselor and is a clinical supervisor for a Community YMCA. Tracy has over 12 years of experience working in many settings including partial care hospitalization and intensive outpatient programs, community agencies, group practice, and school-based programs. Tracy works with clients of all ages, but especially enjoys working with the adolescents.
Related Articles